Abstract: A device for providing a realistic media content, includes: inward facing image acquisition unit configured to acquire multiple inward facing images that are taken by an inward method using multiple cameras arranged around an object; an outward facing image acquisition unit configured to acquire multiple outward facing images that are taken by an outward method using the multiple cameras arranged around a point; a background image generation unit configured to generate a 360° cylindrical image by stitching the multiple outward facing images and then convert the 360° cylindrical image into a 360° spherical image to generate a background image; a 3D object reconstruction unit configured to extract a region of the object from the multiple inward facing images to generate a 3D object; and a combined image transmission unit configured to combine the background image with the 3D object and transmit the combined image to a display device.

Abstract: Provided is a hybrid multi-band antenna array, including: a multilayer substrate board including a ground conductor structure having a first edge; a first antenna array including a plurality of folded loop antennas, all of which being integrated with the multilayer substrate board and arranged along the first edge sequentially, wherein the first antenna array is excited to generate a first resonant mode covering at least one first communication band; and a second antenna array including a plurality of parallel-connected slot antennas, all of which being integrated with the multilayer substrate board and arranged along the first edge sequentially, wherein the second antenna array is excited to generate a second resonant mode covering at least one second communication band, and a frequency of the second resonant mode is lower than a frequency of the first resonant mode.

Abstract: A molecule that binds specifically to a human tissue plasminogen activator (TPA) or a TPA mutant is provided. The molecule having sub-nanomolar affinity to inhibit fibrin-dependent plasminogen activation with an IC50<5 nM, to inhibit degradation of human fibron clots without affecting TPA amidolytic activity or non-fibrin-dependent activation, and the amino acid sequence of the TPA mutant is at least 65% identical to SEQ ID NO: 1 or SEQ ID NO: 2. Further provided is a method for treating systemic bleeding and brain hemorrhage after TPA treatment in a patient in need of such treatment. The method comprises administering to said patient an effective amount of the molecule, wherein the molecule selectively inhibits fibrin-augmented plasminogen activation in the patient.

Abstract: Devices for non-invasive, label-free separation of particles in liquid, including circulating tumors cells in blood, are provided. Embodiments of the disclosure provide for devices employing magnetic fluids and magnets for separation of circulating tumor cells from blood. Methods for separation of particles including circulating tumor cells are also provided.

Abstract: Rechargeable, high-density electrochemical devices are disclosed. These electrochemical devices may, for example, include high energy densities that store more energy in a given, limited volume than other batteries and still show acceptable power or current rate capability without any liquid or gel-type battery components. Certain embodiments may involve, for example, low volume or mass of all of the battery components other than the cathode, while simultaneously achieving high electrochemically active mass inside the positive cathode.

Abstract: A method for fabrication of high electron mobility transistor (HEMT) semiconductor devices is presented. The method includes providing a substrate, growing a HEMT layer structure on the substrate; and self-aligned common metal stack formation of source, drain and gate electrodes on the HEMT layer structure using a single lithographic mask.

Abstract: A method and system for annotating Playable Media Files in a social network having a plurality of members, wherein the method includes receiving the Playable Media File from a first member, receiving an annotation from another member, and saving the annotation in a file other than the Playable Media File.

Abstract: The present invention provides methods for treating cancers having a mutation in one or more tumor suppressor genes, comprising providing to a subject in need thereof an inhibitor of a kinase, as well as related methods and compositions.

Abstract: A fiber optic cable assembly suitable for providing mesh connectivity includes a fiber shuffle region arranged between first and second cable assembly sections that each include multiple tubes each containing a group of optical fibers, with a jacket provided over one or both cable assembly sections. The fiber shuffle region may be compact in width and length, and integrated into a trunk cable. Optical fibers remain in sequential order in groups at ends of the cable assembly sections, where the fibers may be ribbonized and/or connectorized. A fabrication method for such a fiber optic cable assembly is also disclosed.

Abstract: A tunnel field effect transistor (TFET) device includes a substrate, heavily doped source and drain regions disposed at opposite ends of a channel region forming a PiN or NiP structure, the channel region including a first substantially parallelogram portion having a first length defined along a longitudinal axis extending from the source region to the drain region and a second substantially parallelogram portion having a second length defined along the longitudinal axis larger than the first length, the TFET device having an effective channel length that is an average of the first and second lengths. The channel region includes a channel material with a first effective mass along a longitudinal axis extending from the source region to the drain region and a second effective mass along a lateral axis perpendicular to the longitudinal axis, the first effective mass being greater than the second effective mass.

Abstract: The present invention is directed at a waveguide antenna for microwave enhanced combustion of a previously ignited fuel-air mixture. The waveguide antenna has a thermal conductivity of at least 150 W/m?k and can be formed from a metallic shell with a ceramic core.

Abstract: A method of identifying bounded hydrocarbon formations of interest in a seismic data set includes obtaining a seismic data set, pre-processing the seismic data set, inputting the plurality of graphical model inputs and one or more rules to a graphical model, wherein the rules define a relationship between a plurality of attributes of a bounded hydrocarbon formation, running a graphical model on the graphical model inputs, post-processing the graphical model outputs, and displaying the ranked clusters in order of rank.

Abstract: A non-invasive system, and method for simple, quantitative screening for mTBI and other forms of mid cognitive impairment using a visuo-motor performance test (for example, a submaximal grip test) in response to visual feedback to quantitatively measure the intra-individual variability of performance metric for initial screening of patients with mild traumatic brain injury (mTBI), and other neurological disorders. The system and method can be administered in minutes, by any level of caregiver, in any environment including military in-the-field or sports on-field deployments, and is useful in screening those truly injured from those disguising or mimicking injury. In addition to screening, the system and method can be used to monitor and/or detect changes to intra-individual variability over time by comparison to a baseline, which in turn is helpful in determining estimated recovery trajectory or other related information.

Abstract: A method for depressurizing a vehicular fuel storage system including a first portion and a second portion, the first portion being in fluid communication with a closable filler head opening, the first portion being separated from the second portion by a valve, the method including: in a first time period, depressurizing the first portion by bringing the first portion in communication with the atmosphere, while the valve and the filler head opening are closed; in a second time period, depressurizing the second portion by bringing the second portion in communication with the atmosphere; and obtaining readiness for access to the filler head opening as from the end of the first time period.

Abstract: The process comprises delivering a spray solution comprising an active agent and a matrix material in an organic solvent to a spray-drying apparatus, atomizing the spray solution into droplets within the spray-drying apparatus to remove at least a portion of the organic solvent from the droplets to form a plurality of particles, and collecting the particles. The spray solution may be formed by forming a feed suspension comprising the active agent, the matrix material, and the organic solvent, wherein the feed suspension is at a temperature T1, and directing the feed suspension to a heat exchanger, thereby increasing the temperature of the feed suspension to a temperature T2, wherein T2 is greater than T1, and the spray solution is at a pressure greater than the vapor pressure of the organic solvent at T2, such that the active agent and matrix material are soluble in the organic solvent at T2.

Abstract: A system and method is provided to acquire images of a subject having received a tissue soluble hyperpolarized gas into the airways. The method includes performing a pulse sequence including (i) for each effective repetition time (TReff), acquiring at least one gas-phase dataset and at least one dissolved-phase dataset, wherein a gas-phase echo time (TEGas) of the at least one gas-phase dataset and a dissolved-phase echo time (TEDissolved) of the at least one dissolved-phase dataset are selected to isolate gas-phase contamination of the dissolved-phase dataset from dissolved-phase components in the dissolved-phase dataset.

Abstract: An ambulatory infusing device including a housing, a reservoir defining an interior volume, a wall associated with the housing and having an inner surface that faces into the reservoir interior volume, and a filter assembly. The filter assembly may include a filter assembly housing with a housing filter portion having a free end associated with the inner surface of the wall and a filter supporting volume that extends to the free end of the housing filter portion, and a filter located within the filter supporting volume that extends to at least the free end of the housing filter portion.

Abstract: In a process for producing one or more 2,X?-dimethyl biphenyl isomers (where X=2, 3 or 4), a feed comprising toluene is contacted with hydrogen in the presence of a hydroalkylation catalyst under conditions effective to produce a hydroalkylation reaction product comprising (methylcyclohexyl)toluene. At least part of the hydroalkylation reaction product is dehydrogenated in the presence of a dehydrogenation catalyst under conditions effective to produce a dehydrogenation reaction product comprising dimethyl biphenyl isomers. The dehydrogenation reaction product is then separated into at least a first stream comprising one or more 3,3?-, 3,4?- and 4,4?-dimethyl biphenyl isomers and at least one second stream comprising one or more 2,X?-dimethyl biphenyl isomers (where X=2, 3 or 4).

Abstract: This disclosure relates to extracts from chestnut plants and compositions comprising compounds contained therein. In certain embodiments, the extracts are derived from the leaves of a Castanea plant. In certain embodiments, the disclosure relates to methods of treating or preventing bacterial infections, acne, and other related uses.

Abstract: The present disclosure relates to protein molecules that specifically bind to CD123, which may have at least one humanized or human CD123-binding domain. Such molecules are useful for the treatment of cancer. The protein molecule binding to CD123 may have a second binding domain that binds to another target. In one embodiment, multi-specific polypeptide molecules bind both CD123-expressing cells and the T-cell receptor complex on T-cells to induce target-dependent T-cell cytotoxicity, activation, and proliferation. The disclosure also provides pharmaceutical compositions comprising the CD123-binding polypeptide molecules, nucleic acid molecules encoding these polypeptides and methods of making these molecules.